A Comparative Study Between Lysine Clonixinate+Cyclobenzaprine and Caffeine+Carisoprodol+Sodium Diclofenac+Paracetamol

• Status: Unknown status
• Trial end date: 2013-01-01

Summary

Non inferiority, multicentric, double blind study whose the primary objective is to compare the effectiveness of two products in pain reduction. Primary endpoint: reduction in pain average at day 7 compared to day 1(baseline), using Analogue Visual Scale (AVS) for pain evaluation. Secondary endpoint: to evaluate the products safety at the gastrointestinal system.

• Phase: Phase 3

Details

• Lead Sponsor: Farmoquimica S.A.
• Collaborator: Pharmagenix Projetos em Medicina Farmacêutica Ltda.
• Treatments: Acetaminophen; Amitriptyline; Anti-Inflammatory Agents, Non-Steroidal; Caffeine; Carisoprodol; Clonixin; Cyclobenzaprine; Diclofenac